Tumor immune escape mechanisms: impact of the neuroendocrine system Kerstin LangFrank EntschladenKurt S. Zaenker Review 25 January 2006 Pages: 749 - 760
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma Brian S. ChoiPaul M. SondelMark R. Albertini Original Article 27 September 2005 Pages: 761 - 774
Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer Kanji TakahashiHideyoshi ToyokawaYasuo Kamiyama Original Article 16 September 2005 Pages: 775 - 784
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3 Bernd SchlerethPetra KleindienstPatrick A. Baeuerle Original Article 27 September 2005 Pages: 785 - 796
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen Irma M. SainzIrma Isordia-SalasRobert W. Colman Original Article 27 September 2005 Pages: 797 - 807
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes Monika Baj-KrzyworzekaRafał SzatanekMarek Zembala Original Article 09 November 2005 Pages: 808 - 818
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate Margarita SalcedoNadège BercoviciThierry Velu Original Article 27 September 2005 Pages: 819 - 829
T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC) Astrid Marta OlsnesDmitri MotorinØystein Bruserud Original Article 03 November 2005 Pages: 830 - 840
MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo Wei GeYan-Fang SuiXiu-Min Zhang Original Article 06 September 2005 Pages: 841 - 849
Defining MHC class II T helper epitopes for WT1 tumor antigen Hiroya KobayashiToshihiro NagatoEsteban Celis Original Article 12 October 2005 Pages: 850 - 860
Therapeutic efficacy of tumor-targeted IL2 in LTα−/− mice depends on conditioned T cells David SchramaHeike VoigtJürgen C. Becker Original Article 13 September 2005 Pages: 861 - 866
A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA–A24 carcinoma cells Sabrina OttavianiDidier ColauPierre van der Bruggen Original Article 03 September 2005 Pages: 867 - 872
Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats Jin-Cherng ChenYun ChenSheng-Hong Tseng Original Article 27 August 2005 Pages: 873 - 883
Fifth European progress in vaccination against cancer conference, PIVAC 5 Federica CavalloConstantin N. Baxevanis Meeting Report 12 January 2006 Pages: 884 - 890